Squamolone

Squamolone

SCHEMBL1051735

NC(=O)N1CCCC1=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Squamolone SCHEMBL28367081 0.98 LMNA (0.57)
SCHEMBL4702017 0.93 LMNA (0.52)
SCHEMBL1424272 0.91 LMNA (0.50)
SCHEMBL6538147 0.85
SCHEMBL2594237 0.80 LMNA (0.64)
SCHEMBL8579741 0.79
SCHEMBL21077570 0.79 LMNA (0.52)
SCHEMBL31098685 0.79 LMNA (0.42)
Hydroxyamine SCHEMBL7974682 0.79 LMNA (0.57)
SCHEMBL13792789 0.79 LMNA (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100534990-C Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2009-09-02 CN claimed
US-7067549-B2 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2006-06-27 US claimed
US-20050192292-A1 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2005-09-01 US claimed
CN-1610678-A Pyrrolidone carboxamides ACTELION PHARMACEUTICALS LTD (CH) 2005-04-27 CN claimed
EP-1463724-A1 PYRROLIDONE CARBOXAMIDES Actelion Pharmaceuticals Ltd. (CH) 2004-10-06 EP claimed
WO-2003059905-A1 PYRROLIDONE CARBOXAMIDES ACTELION PHARMACEUTICALS LTD (CH) 2003-07-24 WO claimed
EP-0373226-B1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL CO LTD (JP) 1994-06-15 EP claimed
US-5229402-A Improving cerebral function TAIHO PHARMACEUTICAL COMPANY, LTD. (JP) 1993-07-20 US claimed
EP-0373226-A1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1990-06-20 EP claimed
EP-0187052-B1 ADAMANTAN AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM S.A. PANMEDICA Société dite: (FR) 1990-01-31 EP claimed
EP-0177450-B1 PROCESS FOR THE PREPARATION OF CYCLOHEXANE DIONE CARBOXYLIC-ACID DERIVATIVES WITH A HERBICIDAL AND PLANT-GROWTH REGULATING EFFECT CIBA-GEIGY AG (CH) 1989-03-29 EP claimed
EP-0187052-A1 Adamantan amine derivatives, process for their preparation and medicines containing them S.A. PANMEDICA Société dite: (FR) 1986-07-09 EP claimed
EP-0037990-A1 Phenyl quinolizidines, corresponding pharmaceutical preparations, the preparation of the active compounds and corresponding starting compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-10-21 EP claimed
JP-1265071-A None JP disclosed
CN-121974890-A Crystalline CSF-1R inhibitor acid salt and preparation method and application thereof 上海和誉生物医药科技有限公司 2026-05-05 CN disclosed
EP-4637688-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2025-10-29 EP disclosed
US-4124594-A REACTING AMINO-HYDROXYBUTYRIC ACID WITH A SILYLATING AGENT FOLLOWED BY REACTION WITH A HALOGENATED ESTER, CYCLIZATION I.S.F. SPA (IT) 1978-11-07 US disclosed
US-4003911-A ANTISECRETORY AGENTS, OXYTOCICS, BRONCHODILATORS, PLASTICIZERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-18 US disclosed
US-3996288-A Method of producing aldehydes by hydroformylation AJINOMOTO CO., INC. (JA) 1976-12-07 US disclosed
US-3948943-A THERAPEUTIC, DERMATOLOGICAL, COSMETIC BOEHRINGER INGELHEIM GMBH (DT) 1976-04-06 US disclosed